Sangamo Therapeutics
SGMO
SGMO
113 hedge funds and large institutions have $39.6M invested in Sangamo Therapeutics in 2025 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 30 increasing their positions, 32 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
7% less funds holding
Funds holding: 121 → 113 (-8)
29% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 24
Holders
113
Holding in Top 10
1
Calls
$756K
Puts
$727K
Top Buyers
| 1 | +$1.99M | |
| 2 | +$692K | |
| 3 | +$658K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$345K |
| 5 |
Squarepoint
New York
|
+$332K |
Top Sellers
| 1 | -$1.31M | |
| 2 | -$692K | |
| 3 | -$561K | |
| 4 |
Millennium Management
New York
|
-$437K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$430K |
